Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Towards robust foundation models for digital pathology.

Nature communications·2026
Same author

Beyond attention heatmaps: How to get better explanations for multiple instance learning models in histopathology.

Medical image analysis·2026
Same author

AI-based discovery of functional boundaries in the human brain from intraoperative electrophysiology.

medRxiv : the preprint server for health sciences·2026
Same author

Modeling attention and binding in the brain through bidirectional recurrent gating.

Nature communications·2026
Same author

How simple can you go? An off-the-shelf transformer approach to molecular dynamics.

The Journal of chemical physics·2026
Same author

Software for dataset-wide XAI: From local explanations to global insights with Zennit, CoRelAy, and ViRelAy.

PloS one·2026

Related Experiment Video

Updated: Jun 5, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

StructRank: a new approach for ligand-based virtual screening.

Fabian Rathke1, Katja Hansen, Ulf Brefeld

  • 1Department of Machine Learning, University of Technology, Berlin, Germany. fabian.rathke@iwr.uni-heidelberg.de

Journal of Chemical Information and Modeling
|December 21, 2010
PubMed
Summary
This summary is machine-generated.

This study introduces StructRank, a novel Support Vector Machine-based algorithm for ranking chemical compounds in drug discovery. StructRank directly addresses early recognition challenges, outperforming existing regression and ranking methods in identifying active molecules.

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Experiment Videos

Last Updated: Jun 5, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Area of Science:

  • Computational chemistry
  • Cheminformatics
  • Drug discovery

Background:

  • Drug discovery involves screening large chemical libraries against biological targets.
  • Virtual screening (VS) is a key computational method for ranking compounds.
  • Current Quantitative Structure-Activity Relationship (QSAR) models often use regression, which may not optimize early recognition of active compounds.

Purpose of the Study:

  • To propose a novel top-k ranking algorithm, StructRank, for direct early recognition in virtual screening.
  • To evaluate StructRank's performance against established regression and ranking methods in QSAR.

Main Methods:

  • Development of StructRank, a ranking algorithm based on Support Vector Machines.
  • Application of StructRank to the problem of identifying active molecules in large chemical libraries.
  • Empirical comparison of StructRank with traditional regression-based QSAR and RankSVM.

Main Results:

  • StructRank directly addresses the early recognition problem in virtual screening.
  • The proposed ranking approach demonstrates superior performance compared to standard regression methods.
  • StructRank outperforms RankSVM, a recently proposed QSAR ranking approach, in identifying active compounds.

Conclusions:

  • StructRank offers a more effective strategy for early recognition in virtual screening compared to existing methods.
  • The algorithm's performance suggests its utility in prioritizing compounds for experimental validation in drug discovery.
  • This work advances QSAR methodologies by directly tackling the ranking problem for improved drug candidate identification.